Large-scale integration of the non-coding RNAs with DNA methylation in human cancers

Cell Rep. 2023 Mar 28;42(3):112261. doi: 10.1016/j.celrep.2023.112261. Epub 2023 Mar 15.

Abstract

Characterizing influences of DNA methylation (DNAm) on non-coding RNAs (ncRNAs) is important to understand the mechanisms of gene regulation and cancer outcome. In our study, we describe the results of ncRNA quantitative trait methylation sites (ncQTM) analyses on 8,545 samples from The Cancer Genome Atlas (TCGA), 763 samples from the Clinical Proteomic Tumor Analysis Consortium (CPTAC), and 516 samples from Genotype-Tissue Expression (GTEx) to identify the significant associations between DNAm sites and ncRNAs (miRNA, long non-coding RNA [lncRNA], small nuclear RNA [snRNA], small nucleolar RNA [snoRNA], and rRNA) across 32 cancer types. With more than 22 billion tests, we identify 302,764 cis-ncQTMs (6.28% of all tested) and 79,841,728 trans-ncQTMs (1.15% of all tested). Most DNAm sites (70.6% on average) are in trans association, while only 25.2% DNAm sites are in cis association. Further, we develop a subtype named ncmcluster based on cancer-specific ncRNAs thatis associated with tumor microenvironment, clinical outcome, and biological pathways. To comprehensively describe the ncQTM patterns, we developed a database named Pancan-ncQTM (http://bigdata.njmu.edu.cn/Pancan-ncQTM/).

Keywords: CP: Cancer; DNA methylation; multi-omics; non-coding RNA; overall survival; pan-cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Methylation / genetics
  • Humans
  • MicroRNAs*
  • Neoplasms* / genetics
  • Proteomics
  • RNA, Long Noncoding* / genetics
  • RNA, Small Nucleolar
  • RNA, Untranslated / genetics
  • Tumor Microenvironment

Substances

  • RNA, Untranslated
  • MicroRNAs
  • RNA, Long Noncoding
  • RNA, Small Nucleolar